BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24161911)

  • 1. The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophy.
    Taglieri DM; Johnson KR; Burmeister BT; Monasky MM; Spindler MJ; DeSantiago J; Banach K; Conklin BR; Carnegie GK
    J Mol Cell Cardiol; 2014 Jan; 66():27-40. PubMed ID: 24161911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy.
    Pérez López I; Cariolato L; Maric D; Gillet L; Abriel H; Diviani D
    Mol Cell Biol; 2013 Aug; 33(15):2903-17. PubMed ID: 23716597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide Gene Expression Analysis Shows AKAP13-Mediated PKD1 Signaling Regulates the Transcriptional Response to Cardiac Hypertrophy.
    Johnson KR; Nicodemus-Johnson J; Spindler MJ; Carnegie GK
    PLoS One; 2015; 10(7):e0132474. PubMed ID: 26192751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway.
    Carnegie GK; Soughayer J; Smith FD; Pedroja BS; Zhang F; Diviani D; Bristow MR; Kunkel MT; Newton AC; Langeberg LK; Scott JD
    Mol Cell; 2008 Oct; 32(2):169-79. PubMed ID: 18951085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src homology 2 domain-containing phosphatase 2 (Shp2) is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex and is inhibited by protein kinase A (PKA) under pathological hypertrophic conditions in the heart.
    Burmeister BT; Taglieri DM; Wang L; Carnegie GK
    J Biol Chem; 2012 Nov; 287(48):40535-46. PubMed ID: 23045525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-kinase anchoring protein-Lbc promotes pro-fibrotic signaling in cardiac fibroblasts.
    Cavin S; Maric D; Diviani D
    Biochim Biophys Acta; 2014 Feb; 1843(2):335-45. PubMed ID: 24269843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKAP13 Rho-GEF and PKD-binding domain deficient mice develop normally but have an abnormal response to β-adrenergic-induced cardiac hypertrophy.
    Spindler MJ; Burmeister BT; Huang Y; Hsiao EC; Salomonis N; Scott MJ; Srivastava D; Carnegie GK; Conklin BR
    PLoS One; 2013; 8(4):e62705. PubMed ID: 23658642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.
    Ling H; Zhang T; Pereira L; Means CK; Cheng H; Gu Y; Dalton ND; Peterson KL; Chen J; Bers D; Brown JH
    J Clin Invest; 2009 May; 119(5):1230-40. PubMed ID: 19381018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
    Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
    Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade.
    Niizeki T; Takeishi Y; Kitahara T; Arimoto T; Ishino M; Bilim O; Suzuki S; Sasaki T; Nakajima O; Walsh RA; Goto K; Kubota I
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H245-55. PubMed ID: 18487437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ubiquitin-like protein LC3 regulates the Rho-GEF activity of AKAP-Lbc.
    Baisamy L; Cavin S; Jurisch N; Diviani D
    J Biol Chem; 2009 Oct; 284(41):28232-28242. PubMed ID: 19696020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKAP-Lbc mediates protection against doxorubicin-induced cardiomyocyte toxicity.
    Caso S; Maric D; Arambasic M; Cotecchia S; Diviani D
    Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2336-2346. PubMed ID: 28923249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
    Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
    Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction.
    Mori J; Basu R; McLean BA; Das SK; Zhang L; Patel VB; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
    Circ Heart Fail; 2012 Jul; 5(4):493-503. PubMed ID: 22705769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The A-kinase-anchoring protein AKAP-Lbc facilitates cardioprotective PKA phosphorylation of Hsp20 on Ser(16).
    Edwards HV; Scott JD; Baillie GS
    Biochem J; 2012 Sep; 446(3):437-43. PubMed ID: 22731613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy-mediated degradation is necessary for regression of cardiac hypertrophy during ventricular unloading.
    Oyabu J; Yamaguchi O; Hikoso S; Takeda T; Oka T; Murakawa T; Yasui H; Ueda H; Nakayama H; Taneike M; Omiya S; Shah AM; Nishida K; Otsu K
    Biochem Biophys Res Commun; 2013 Nov; 441(4):787-92. PubMed ID: 24211573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Kinase D1 Regulates Cardiac Hypertrophy, Potassium Channel Remodeling, and Arrhythmias in Heart Failure.
    Bossuyt J; Borst JM; Verberckmoes M; Bailey LRJ; Bers DM; Hegyi B
    J Am Heart Assoc; 2022 Oct; 11(19):e027573. PubMed ID: 36172952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy.
    Appert-Collin A; Cotecchia S; Nenniger-Tosato M; Pedrazzini T; Diviani D
    Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10140-5. PubMed ID: 17537920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histone acetyltransferase MOF overexpression blunts cardiac hypertrophy by targeting ROS in mice.
    Qiao W; Zhang W; Gai Y; Zhao L; Fan J
    Biochem Biophys Res Commun; 2014 Jun; 448(4):379-84. PubMed ID: 24802406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.